Difference between revisions of "Part:BBa K4586003"
(→Part Description) |
Ahmed Mattar (Talk | contribs) (→Usage) |
||
Line 9: | Line 9: | ||
==Usage== | ==Usage== | ||
This conditioned promoter is implemented in our design as it has a high level of transcriptional activity and is regulated by the VP64 released from the internal domain of our syn notch receptor. | This conditioned promoter is implemented in our design as it has a high level of transcriptional activity and is regulated by the VP64 released from the internal domain of our syn notch receptor. | ||
− | The ZF21.16 promoter is used in our design to control the expression of our cargo circuit or our therapeutic agent, which contains (switch + Cas12/gBAFF-R), which has a high level of transcriptional activity and is regulated by the VP64 released from the internal domain of our syn notch receptor. | + | The ZF21.16 promoter is used in our design to control the expression of our cargo circuit or our therapeutic agent, which contains (switch + Cas12/gBAFF-R), which has a high level of transcriptional activity and is regulated by the VP64 released from the internal domain of our syn notch receptor as shown in figure 1. |
− | + | <html><div align="center"style="border:solid #17252A; width:100%;float:center;"><img style=" max-width:850px; | |
+ | width:100%; | ||
+ | height:auto; | ||
+ | position: relative; | ||
+ | top: 50%; | ||
+ | left: 45%; | ||
+ | transform: translate( -50%); | ||
+ | padding-bottom:25px; | ||
+ | padding-top:25px; | ||
+ | "src="https://static.igem.wiki/teams/4586/wiki/parts/3-21-25.png | ||
+ | "> | ||
+ | <p class=MsoNormal align=center style='text-align:left;border:none;width:98% ;justify-content:center;'><span | ||
+ | lang=EN style='font-size:11.0pt;line-height:115%'>Figure 1: This figure illustrates the design of our biological circuit expressing our therapeutic agent under the control of the VP64 transcription module that regulates the activity of the ZF21.16minCMV promoter. </span></p></div></html> | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 12:40, 22 September 2023
ZF21.16 minCMV Promoter
Part Description
This part codes for conditional promoter its activity based on VP64 transcription factor This promoter is designed to contain multiple repeats recognized by the zinc finger protein 21.16 to direct VP64 activity toward this promoter.it has a high level of transcriptional activity, and it is demonstrated that ZF21 encourages focal adhesion turnover and ECM breakdown at the invadopodia, which suppresses tumor growth.
Usage
This conditioned promoter is implemented in our design as it has a high level of transcriptional activity and is regulated by the VP64 released from the internal domain of our syn notch receptor. The ZF21.16 promoter is used in our design to control the expression of our cargo circuit or our therapeutic agent, which contains (switch + Cas12/gBAFF-R), which has a high level of transcriptional activity and is regulated by the VP64 released from the internal domain of our syn notch receptor as shown in figure 1.
Figure 1: This figure illustrates the design of our biological circuit expressing our therapeutic agent under the control of the VP64 transcription module that regulates the activity of the ZF21.16minCMV promoter.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]